Accéder au contenu
Merck

RU 24969-produced adipsia and hyperlocomotion: differential role of 5HT 1A and 5HT 1B receptor mechanisms.

Pharmacology, biochemistry, and behavior (2014-05-23)
Dane Aronsen, Jeremy Webster, Susan Schenk
RÉSUMÉ

RU 24969 is a widely used, but non-selective, 5-HT1B/1A agonist that decreases fluid consumption and increases forward locomotion. The mechanism underlying these behavioural responses is not, however, well understood. Accordingly, effects of the selective 5-HT1A and 5-HT1B antagonists, WAY 100635, and GR 127935, respectively, on these two responses to RU 24969 were determined. RU 24969 (0.03-3.0mg/kg, s.c.) dose-dependently decreased water consumption in water deprived rats. This effect was attenuated by GR 127935 (3.0mg/kg), but not by WAY 100635 (1.0mg/kg). RU 24969 (0.3-3.0mg/kg) dose-dependently increased forward locomotion but a higher dose was required to produce this response than the adipsic response. The increased locomotor response was attenuated by WAY 100635 (1.0mg/kg), but not GR 127935 (3.0mg/kg). These results suggest that RU 24969-induced adipsia is mediated by 5-HT1B mechanisms, while RU 24969-induced hyperlocomotion is mediated by 5-HT1A mechanisms.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
RU 24969 hemisuccinate, ≥98% (HPLC)